Literature DB >> 407161

Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant.

S C Bruins, R Stumacher, M A Johns, W R McCabe.   

Abstract

The protective effect of active immunization with Salmonella minnesota Re bacilli or lipid A was assessed in the granulocytopenic rabbit model. Animals were immunized with Re bacilli, lipid A, or Pseudomonas aeruginosa as a nonspecific immunogen. After colonization with one of three enterobacterial strains (two Escherichia coli, one Enterobacter aerogenes), the immunized rabbits as well as controls given saline injections were made leukopenic with nitrogen mustard and monitored for fever, bacteremia, and death. Survival rates were significantly greater in Re-immunized animals than in saline controls or P. aeruginosa-immunized animals. Immunization with lipid A afforded no protection. In addition, rabbits immunized with Re mutant bacilli developed bacteremia less frequently than the others, indicating that antibody to Re may inhibit invasion of the intestinal mucosa as well as protect after bacteremia has developed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407161      PMCID: PMC421075          DOI: 10.1128/iai.17.1.16-20.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant.

Authors:  E J Ziegler; H Douglas; J E Sherman; C E Davis; A I Braude
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

2.  Passive immunization against the local Shwartzman reaction.

Authors:  A I Braude; H Douglas
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

3.  Protection against gram-negative infections with antiserum to lipid A from Salmonella minnesota R595.

Authors:  N A Mullan; P M Newsome; P G Cunnington; G H Palmer; M E Wilson
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

4.  Protection against lethality of E. coli endotoxin with "O" antiserum.

Authors:  W J Tate; H Douglas; A I Braude; W W Wells
Journal:  Ann N Y Acad Sci       Date:  1966-06-30       Impact factor: 5.691

5.  Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin.

Authors:  E T Rietschel; Y B Kim; D W Watson; C Galanos; O Lüderitz; O Westphal
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

6.  Experimental bacteremia due to Pseudomonas in agranulocytic animals.

Authors:  E J Ziegler; H Douglas; A I Braude
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

7.  Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.

Authors:  W R McCabe
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

8.  Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli.

Authors:  S H Zinner; W R McCabe
Journal:  J Infect Dis       Date:  1976-01       Impact factor: 5.226

9.  Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants.

Authors:  M A Johns; S C Bruins; W R McCabe
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

10.  Studies on hemagglutination and hemolysis by escherichia coli antisera.

Authors:  E NETER; L F BERTRAM; D A ZAK; M R MURDOCK; C E ARBESMAN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

View more
  22 in total

1.  Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A.

Authors:  H M Kuhn; L Brade; B J Appelmelk; S Kusumoto; E T Rietschel; H Brade
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 2.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

Review 3.  Bacteraemia in man and animals: an overview.

Authors:  J Vaid
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

Review 4.  Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.

Authors:  D L Dunn
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

5.  Common lipopolysaccharide specificity: new type of antigen residing in the inner core region of S- and R-form lipopolysaccharides from different families of gram-negative bacteria.

Authors:  H Brade; C Galanos
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

6.  Parameters affecting the enzyme-linked immunosorbent assay of immunoglobulin G antibody to a rough mutant of Salmonella minnesota.

Authors:  S C Bruins; I Ingwer; M L Zeckel; A C White
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

7.  Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.

Authors:  M I Marks; E J Ziegler; H Douglas; L B Corbeil; A I Braude
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

8.  Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.

Authors:  J J Cornelissen; K Maassen; L van Emst; P M Weers; M Harmsen; B J Benaissa-Trouw; T A Oosterlaken; C A Kraaijeveld; J Verhoef
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

9.  Lipid A and anti-lipid A.

Authors:  I Mattsby-Baltzer; B Kaijser
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

10.  Cross-reactivity of monoclonal antibodies and sera directed against lipid A and lipopolysaccharides.

Authors:  H M Kuhn
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.